Drug-facilitated sexual assault

Drug-facilitated sexual assault (DFSA) is sexual assault committed against a person rendered unable to consent or resist by a substance — whether that substance was administered covertly or was already in their system. The incapacitation, not the route of administration, is what defines the category.

Alcohol is the substance most commonly documented in DFSA cases. Sedative-hypnotic compounds — including GHB (gamma-hydroxybutyrate), certain benzodiazepines, and dissociatives such as ketamine — are also documented in covert-administration cases, because they produce rapid sedation and anterograde amnesia at doses that may be difficult to detect by taste or appearance in a drink.

How it is done

DFSA typically follows one of two patterns. In covert administration, a substance is introduced to a person's food or drink without their knowledge. In opportunistic DFSA, a perpetrator acts against a person who has already become incapacitated — whether by voluntary intoxication or other means.

The pharmacological properties most associated with the pattern are rapid onset, sedation and muscle relaxation, and anterograde amnesia — the suppression of new memory formation during the event. GHB produces all three and is eliminated from the body quickly. Benzodiazepines produce sedation and amnesia over a longer window. Alcohol potentiates both classes and is itself often a factor even when other substances are also present.

When it matters

If a person suspects they have been drugged — confusion, unexplained sedation, gaps in memory, or waking in an unexpected state or location — the detection window is already narrowing. Blood and urine samples collected as soon as possible preserve the most pharmacological evidence.

Medical care is the immediate priority: assessment for injury, emergency contraception where relevant, and STI prophylaxis. Forensic evidence collection is time-sensitive independently of toxicology. Many jurisdictions have sexual assault nurse examiner programs that can collect evidence for potential later use, without requiring an immediate decision to report.

What it cannot tell you

The most consequential limit in DFSA cases is the detection window. Many of the compounds involved clear from blood within a few hours and from urine within roughly half a day — windows that may close before a person has processed what happened, sought care, or reached a testing facility.

A negative toxicology result, taken some hours after an incident, does not establish that no substance was present. It establishes only that detectable levels were not found at the time of testing. In the absence of a positive result, the pharmacological record cannot confirm or exclude what occurred.

Hair strand analysis can extend the detection window for some compounds to weeks or months, but requires timely collection and specialized laboratory capacity. It cannot establish the timing or dose of what was taken.